BTIG downgraded Inari Medical (NARI) to Neutral from Buy without a price target after Stryker (SYK) entered a definitive agreement to acquire the company for $80 per share in cash. With Inari now trading at a 1% discount to its takeout price, BTIG is downgrading the shares, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NARI:
- Paychex to acquire Paycor HCM, Getty and Shutterstock to merge: Morning Buzz
- Inari Medical downgraded to Hold from Buy at Jefferies
- Morning Movers: Getty Images, Shutterstock surge following merger pact
- Inari Medical downgraded to Equal Weight from Overweight at Wells Fargo
- BofA goes to No Rating on Inari Medical after takeover deal